Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04461314
Other study ID # MedPAC Hotline
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 26, 2020
Est. completion date August 2023

Study information

Verified date July 2020
Source The University of Hong Kong
Contact Ho Cheung William Li, PhD
Phone +85239176634
Email william3@hku.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim: Providing peer counselling service delivered by student counsellors with a medical background via a hotline to drug-abusing youth and young adult aged 35 or below. Objectives: i. To raise anti-drug awareness of young people in general and identify high-risk/hidden drug-abusing youth and young adult aged 35 or below in Hong Kong; and ii. To train university students with a medical background as peer counsellors; and iii. To provide drug abuse hotline service by students with a medical background as peer counsellors to drug-abusing youth and young adult aged 35 or below, and other people who call for help, including drug abusers' family members, friends, and professionals; and iv. To improve the drug-abusing youth and young adult' knowledge about the hazard of drug abuse, negative attitude, and perception towards the drug abuse through the telephone peer counselling service provided by students with medical background; and v. To increase the intention to quit and the help-seeking behavior among the drug-abusing youth and young adult; vi. To increase reduction rate and abstinence rate from drug abuse, and decrease the relapse rate among drug-abusing youth and young adult through the telephone peer counseling service.


Description:

The MedPAC Hotline Service will be promoted to high-risk and drug-abusing youth and young adults through a variety of platforms, namely schools and youth service organizations, industries, community, mass media and internet, social media, posters and snowball approach. The hotline service will operate from 5 p.m. to 9 p.m. on weekday and from 2 p.m. to 8 p.m. on weekend. A peer counsellor or a research assistant will answer the telephone inquiries from 9:30 a.m. to 5 p.m. on weekdays. About 50 university students will be trained as peer counsellors through a structured training programme. The students will be invited to complete the pre, post and 6-month self-administered questionnaire before, immediately and 6-month after the training programme to examine their changes of knowledge of and attitudes towards addiction counselling. A satisfaction survey will also be conducted to measure their perception on the quality of training programme. Peer counsellors will use telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to motivate and encourage drug-abusing or high-risk youth and young adults to rehabilitate from drug abuse, assist them to manage the withdrawal symptoms, and help identify barriers and facilitators to rehabilitate from drug abuse in the telephone counselling. The peer counsellors will give referral advices if the youth and young adult needs appropriated treatment and rehabilitation services. The drug-abusing youth and young adults will be counselled and invited to complete the follow-up questionnaires over the telephone after joining the MedPAC Hotline Service programme for 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups were invited to have urine test to validate the drug abuse abstinence status.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date August 2023
Est. primary completion date August 2023
Accepts healthy volunteers No
Gender All
Age group N/A to 35 Years
Eligibility Inclusion Criteria: - The inclusion criteria of target service group for this quitline programme is that current drug abusers in Hong Kong who should (1) be aged 35 or below, (2) be able to communicate in Cantonese, and (3) have a history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs). - The inclusion criteria of peer counsellors providing counselling service in this quitline programme are those who should (1) be aged 18 - 35, (2) be able to communicate in Cantonese, (3) have a medical background, (4) complete the training courses and pass the evaluation of peer counsellor qualification. Exclusion Criteria: - Those who are psychologically or physically unable to communicate will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
peer-led counselling
About 50 university students will be trained as peer counsellors through a structured training programme. A pre and post and 6-month self-administered questionnaire will be conducted before, immediately and 6-month after the training programme to examine their changes of knowledge and attitudes. A satisfaction survey will also be conducted to measure participants' perception of the quality of the training programme. Drug-abusing youth and young adults will receive telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to rehabilitate from drug abuse. The peer counsellors will give referral advice if the youth and young adult needs appropriate treatment and rehabilitation services. The drug abusers will be counselled and invited to complete the follow-up questionnaires at 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups will be invited to have a urine test to validate the drug abuse abstinence.

Locations

Country Name City State
Hong Kong The University of Hong Kong Hong Kong Pokfulam

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in drug consumption at 12-month follow-up Drug abuser's drug consumption is measured at 12-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will be used for assessing the self-reported change in drug consumption. Baseline and 12 months
Secondary 30 days self-reported drug abstinence at 6-month and 12-month follow-up Self-reported drug abstinence (do not use drug for at least 30 days during the time of follow-up) at 6-month and 12-month. A questionnaire asking the drug use status, quitting experience will be used for assessing the self-reported drug abstinence. Baseline, 6 months and 12 months
Secondary Change in drug consumption at 6-month follow-up Drug abuser's drug consumption is measured at 6-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will br used for assessing the self-reported change in drug consumption. Baseline and 6 months
Secondary Change in relapse risk among the quitters Drug quitter's relapse risk is measured at 12-month follow-up. A questionnaire using Stimulant Relapse Risk Scale (SRRS) with the questions of the intention to use drugs, compulsivity for drugs and impetus and confidence to avoid drugs etc. will be used for assessing the relapse risk at 12-month follow-up. The higher the scores, the higher the relapse risk. Baseline and 12 months
Secondary Change of the contemplation stage Drug abuser's change of the contemplation stage at 6-month and 12-month follow-up. A questionnaire asking the intention to quit drug abuse and experience of drug abstinence to match the stage in contemplation ladder will be used for assessing the contemplation stage at 6-month and 12-month. Baseline, 6 months and 12 months
Secondary Changes of the perceived treatment needs and motivation towards solving the problem of drug abuse Drug abuser's change of perceived treatment needs and motivation towards solving the problem among drug abusers at 6-month and 12-month. A questionnaire using the Treatment Needs/Motivation Scales (TCU MOTForm) will be used for assessing the level of the intention and motivation to receive treatment of solving the drug abuse problem. The higher the scores, the higher the perceived treatment needs and motivation. Baseline, 6 months and 12 months
Secondary Change of self-efficacy of drug abusers to avoid drug use Drug abuser's change of self-efficacy to avoid drug use at 6-month and 12-month follow-up. The Adolescent Relapse Coping Questionnaire (ARCQ) will be used for evaluating the self-efficacy to avoid drug use. It comprises 6 questions for a given condition about drug temptation. The higher the score, the higher the self-efficacy of drug abusers to avoid drug use. Baseline, 6 months and 12 months
Secondary Drug abuser's improvement of knowledge and attitude on drug abuse hazards Drug abuser's improvement of knowledge and attitude on drug abuse hazards at 6-month and 12-month follow-up. A questionnaire asking about the knowledge and attitude on drug abuse with a scale called "knowledge and attitude on drug abuse for drug abuser" will be used for assessing the change of knowledge and attitude on drug abuse. The higher the scores, the better the knowledge and attitude. Baseline, 6 months and 12 months
Secondary Peer counsellor's improvement of knowledge and attitude on drug abuse hazards Peer counsellor's improvement of knowledge and attitude on drug abuse hazards immediately after the training programme and after 6 months will be measured by a scale called "knowledge and attitude on drug abuse for peer counsellor" in a self-reporting structured questionnaire. The higher the scores, the better the knowledge and attitude. Baseline, immediately after the training programme and 6 months
Secondary Satisfaction of peer counsellors to the drug abuse training programme Satisfaction of peer counsellors to the drug abuse training programme will be collected. A questionnaire asking about the comments of content, practicability, speakers from the peer counsellors with the satisfaction scale will be used for evaluating the satisfaction immediately after the training programme. The higher the scores, the greater the satisfaction of the training programme. Immediately after the training programme
See also
  Status Clinical Trial Phase
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT02375516 - Preventing Drug Abuse Among Hispanic Adolescents N/A
Withdrawn NCT01275391 - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use Phase 1/Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT00907309 - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use Phase 1/Phase 2
Completed NCT02228044 - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment N/A
Withdrawn NCT01427465 - Brief Integrative Alcohol Interventions for Adolescents N/A
Completed NCT00350909 - Brief Intervention for Drug Abusing Adolescents Phase 2
Completed NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users Phase 4
Completed NCT00383838 - Self-Selected Brief Alcohol Intervention for Adolescents N/A
Completed NCT00451854 - Student Athlete Testing Using Random Notification N/A
Completed NCT00722644 - Cognitive Behavioral Stress Management for HIV+ Drug Abusers Phase 1
Completed NCT01036711 - Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
Terminated NCT02741076 - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain Phase 4
Completed NCT01035723 - Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
Completed NCT06044363 - Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders N/A
Recruiting NCT05037487 - Evaluation of Smoked THC and CBD in Men and Women Phase 1
Recruiting NCT04725266 - A Family-based Intervention for Drug-abusing Adults in Hong Kong N/A
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A